year
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 38562-01-5 | ||
EC NO: | 254-002-3 | ||
Molecular Formula: | C24H45NO8 | ||
Molecular Weight: | 475.616 | ||
Specification: | |||
InChI: | InChI=1/C20H34O5.C4H11NO3/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25;5-4(1-6,2-7)3-8/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25);6-8H,1-3,5H2/b7-4+,13-12+;/t15-,16+,17+,18-,19+;/m0./s1 | ||
Synonyms: | prostaglandin F2A tris;prostaglandin F2A gamma-irradiated;dinoprost, trometamol salt;prostaglandin F2-alpha, trometamol salt;Prostaglandin F2alpha tris salt;Dinoprost Tromethamine;Dinoprost tromethamine; (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid;(5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid-2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1);(5E,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid-2-amino-2-(hydroxymethyl)propane-1,3-diol (1:1);Dinoprost Trometamol;Dinorprost tromethamine; | ||
Molecular Structure: |